Results 131 to 140 of about 20,735 (212)

A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.

PLoS Neglected Tropical Diseases, 2019
Nipah virus (NiV) is a highly pathogenic re-emerging virus that causes outbreaks in South East Asia. Currently, no approved and licensed vaccine or antivirals exist.
Neeltje van Doremalen, Teresa Lambe, Sarah Sebastian, Trenton Bushmaker, Robert Fischer, Friederike Feldmann, Elaine Haddock, Michael Letko, Victoria A Avanzato, Ilona Rissanen, Rachel LaCasse, Dana Scott, Thomas A Bowden, Sarah Gilbert, Vincent Munster   +14 more
doaj   +1 more source

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse [PDF]

Viral haemorrhagic fevers (VHF) pose a significant threat to human health. In recent years, VHF outbreaks caused by Ebola, Marburg and Lassa viruses have caused substantial morbidity and mortality in West and Central Africa.
Appelberg, Sofia, Bibi, Sagida, Cha, Kuan M., Dowall, Stuart, Easterbrook, Linda, Findlay-Wilson, Stephen, Flaxman, Amy, Gilbert, Sarah, Gilbride, Ciaran, Lambe, Teresa, Mirazimi, Ali, Purushotham, Jyothi, Schmidt, Isabel, Sebastian, Sarah, Sharpe, Hannah, Spencer, Alexandra J., Ulaszewska, Marta, Wright, Daniel   +17 more
core   +2 more sources

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

Scientific Reports
To evaluate immune responses to COVID-19 vaccines in adults aged 50 years and older, spike protein (S)-specific antibody concentration, avidity, and function (via angiotensin-converting enzyme 2 (ACE2) inhibition surrogate neutralization and antibody ...
Gabrielle N. Gaultier, Brynn McMillan, Chad Poloni, Mandy Lo, Bing Cai, Jean J. Zheng, Hannah M. Baer, Hennady P. Shulha, Karen Simmons, Ana Citlali Márquez, Sofia R. Bartlett, Laura Cook, Megan K. Levings, Theodore Steiner, Inna Sekirov, James E. A. Zlosnik, Muhammad Morshed, Danuta M. Skowronski, Mel Krajden, Agatha N. Jassem, Manish Sadarangani   +20 more
doaj   +1 more source

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes [PDF]

, 2022
Abdul-Jawad, Sultan, Alaguthurai, Thanussuyah, Beatson, Richard, Doores, Katie J, Graham, Carl, Graham, Rosalind, Irshad, Sheeba, Kulasekararaj, Austin, Lechmere, Thomas, Patten, Piers Em, Vidler, Jennifer   +10 more
core   +4 more sources

Depression following ChAdOx1-S/nCoV-19 vaccine

The European Journal of Psychiatry, 2022
openaire   +2 more sources

Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination [PDF]

Journal of Medical Virology, 2021
Sylvia Ai, Alexander Awford, Fernando Roncolato   +2 more
openaire   +1 more source

The systemic-prime, mucosal-boost vaccine regimen for protection against respiratory viruses [PDF]

Respiratory viruses, such as influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, continue to impose a significant global health burden despite the availability of licensed vaccines. While current vaccines that are generally administered via the
Bissett, Cameron
core   +2 more sources

Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19

Medicina Intensiva (English Edition), 2022
Morales Varas, G., Calle Flores, A., Sánchez Casado, M.   +2 more
openaire   +3 more sources

Cutaneous polyarteritis nodosa following ChAdOx1 nCoV‐19 vaccination [PDF]

International Journal of Dermatology, 2022
Hsuan‐An Su, Hui‐Te Hsu, Yu‐Chia Chen   +2 more
openaire   +2 more sources

Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination [PDF]

The Lancet Gastroenterology & Hepatology, 2021
Öcal, Osman, Stecher, Stephanie-Susanne, Wildgruber, Moritz   +2 more
openaire   +2 more sources